Effects of angiotensin I and antiotensin II on canine hepatic vascular resistance.
D000804:Angiotensin II / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001120:Arginine / Q000494:pharmacology; D001783:Blood Flow Velocity; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D006499:Hepatic Artery / Q000187:drug effects*; D007269:Injections, Intra-Arterial; D008297:Male; D009842:Oligopeptides / Q000494:pharmacology; D010477:Perfusion; D012521:Sarcosine / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects*
D000806:Angiotensin-Converting Enzyme Inhibitors; D009842:Oligopeptides; D000804:Angiotensin II; D001120:Arginine; D012521:Sarcosine